Outcome of Idiopathic Pulmonary Fibrosis With Pregnancy
NCT04775277 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 63
Last updated 2021-03-01
Summary
case-control study was conducted between December 2018 to April 2020. To document outcome of IPF with pregnancy.
Conditions
Sponsors & Collaborators
-
Sohag University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 38 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-12-01
- Primary Completion
- 2020-04-30
- Completion
- 2021-02-20
Countries
- Egypt
Study Locations
More Related Trials
-
Prospective Study of Pregnancy in Women With Cystic Fibrosis
NCT04828382 ·Status: ACTIVE_NOT_RECRUITING
-
A Prospective Study of Cyclophosphamide Treatment for Idiopathic Retroperitoneal Fibrosis
NCT04762810 ·Status: UNKNOWN ·Phase: PHASE4
-
Epididymis Protein 4 and Pulmonary Function With Quality Improvement Protocol Among Cystic Fibrosis Patients
NCT06915961 ·Status: RECRUITING
-
Study of Metabolic Effects of Pregnancy in Women With Cystic Fibrosis
NCT00014768 ·Status: TERMINATED
-
Treatment of Idiopathic Pulmonary Fibrosis With Thalidomide
NCT00162760 ·Status: COMPLETED ·Phase: PHASE2
-
Mucin in Sputum of CF During Pulmonary Exacerbation
NCT00202072 ·Status: UNKNOWN
-
Comparison Between Ultra-low-dose Computed Tomography and Lung MRI in Cystic Fibrosis
NCT04644471 ·Status: COMPLETED ·Phase: NA
-
A Comparison of Clinical Parameters in With and Without Abnormal Glucose Tolerance.
NCT04503408 ·Status: COMPLETED
-
Explanted Lung Tissues With Pulmonary Fibrosis
NCT00515567 ·Status: RECRUITING
-
18FDG-PET Imaging to Detect Changes in Airways Inflammation in Cystic Fibrosis Patients
NCT00684346 ·Status: COMPLETED ·Phase: PHASE3
-
Muscle Accrual and Function in Cystic Fibrosis-Impact of Glucose Intolerance
NCT02776098 ·Status: COMPLETED
-
Near Patient Microbial Testing in Cystic Fibrosis
NCT01877707 ·Status: COMPLETED ·Phase: NA
-
Safety and Tolerability Study of FG-3019 in Participants With Idiopathic Pulmonary Fibrosis
NCT00074698 ·Status: COMPLETED ·Phase: PHASE1
-
Lung Disease and Its Affect on the Work of White Blood Cells in the Lungs
NCT01851642 ·Status: RECRUITING
-
The Carrier Rates of Pseudomonas Aeruginosa in Family Members of Children With Cystic Fibrosis
NCT01616862 ·Status: COMPLETED
-
Evaluation of Salt Status in Patients With Cystic Fibrosis
NCT04556162 ·Status: COMPLETED
-
COVID-19 Antibody Responses In Cystic Fibrosis
NCT05074680 ·Status: ACTIVE_NOT_RECRUITING
-
Analysis of Specimens From Individuals With Pulmonary Fibrosis
NCT00084305 ·Status: ACTIVE_NOT_RECRUITING
-
CFTR Modulators in Pregnancy and Postpartum
NCT06302270 ·Status: RECRUITING
-
Strength and Muscle Related Outcomes for Nutrition and Lung Function in CF
NCT05639556 ·Status: ACTIVE_NOT_RECRUITING
-
Safety and Tolerability Study of Liquid Alpha1 Proteinase Inhibitor (API) in Subjects With Cystic Fibrosis
NCT01347190 ·Status: COMPLETED ·Phase: PHASE1
-
Prevalence of Chronic Rhinosinusitis in Cystic Fibrosis
NCT00266474 ·Status: COMPLETED
-
Biodistribution of Neutrophile Proteases in the Sputum of Patients Affected by Cystic Fibrosis
NCT00750932 ·Status: COMPLETED
-
Modulation by Sex Hormones of Inflammation and Susceptibility to Pseudomonas Aeruginosa in Cystic Fibrosis Airways
NCT00700050 ·Status: COMPLETED
-
Health Outcomes of Parents With Cystic Fibrosis-Aim 2
NCT06296394 ·Status: RECRUITING